Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-12-18

Clinical Trial Update: Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Brazil comparing levocetirizine/pseudoephedrine versus Zina for allergic rhinitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine/Pseudoephedrine (levocetirizine/pseudoephedrine)
  • Zina

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Allergic Rhinitis | Phase 3 | Status: WITHDRAWN